References
- Coyle N, Mauskop A, Maggard J. Continuous subcutaneous infusions of opiates in cancer patients with pain. Onc Nurs Forum 1986; 13: 153–57
- Campbell C F, Mason J B, Weiler J M. Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Intern Med 1983; 98: 51–52
- Bruera E, Brenneis C, Bacovsky R. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 1988; 62: 407–411
- Payne R. Role of epidural and intrathecal narcotics and peptides in the management of cancer pain. Med Clin North Am 1987; 71: 313–327
- Penn R D, Paice J A. Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67: 182–186
- Lenzi A, Galli G, Gandolfini M. Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: Experience in thirty-eight cases. J Neurosurg 1985; 17: 6–11
- Citron M L, Johnston-Early A, Boyer M. Patient controlled analgesia for severe pain. Arch Intern Med 1986; 146: 734–736
- Kerr I G, Sone M, DeAnpelis C. Continuous narcotic infusion with patient controlled analgesia for chronic cancer pain in outpatients. Ann Intern Med 1988; 108: 554–557
- Moulin D E, Kreeft J H, Murray-Parsons N. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for the management of cancer pain. Lancet 1991; 337: 465–468
- Rutter P C, Murphy F, Dudley H A. Morphine: Controlled trial of different methods of administration for postoperative pain relief. BrMed J 1980; 1: 12–13
- Church J J. Continuous narcotic infusions for relief of postoperative pain. Br Med J 1979; 1: 977–979
- Mapleson W W. An electric analogue for uptake and exchange of inert gases and other agents. J Appl Physiol 1963; 18: 197–204
- Neumann P B, Hendriksen H, Grossman N. Plasma morphine concentrations during chronic oral administration in patients with cancer pain. Pain 1982; 13: 247–252
- Sawe J. High dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokin 1986; 11: 87–106
- Citron M L, Reynolds R J, Lin W N. Clearance of continuous intravenous morphine for cancer pain. Drug Intell Clin Pharm 1987; 21: 1981–985
- Szeto H H, Inturrisi C E, Houde R. Accumulation of nor-meperidine an active metabolite of meperidine in patients with renal failure or cancer. Ann Intem Med 1977; 86: 738–741
- Patwardhan R V, Johnsson R F, Hoyumpa A. Normal metabolism of morphine in cirrhosis. Gastroenterology 1981; 81: 1006–1011
- Mathur L E. Importance of blood concentrations of narcotics: Basis of understanding, controlling, and individualizing therapy. Advanced Pain Research and Therapy, JJ Bonica. Raven Press, New York 1983; 461–466
- Portnoy R K, Moulin D E, Roigers A. IV infusion of opioids for cancer pain: Clinical review and guidelines for use. Cancer Treat Rep 1986; 70: 575–581
- Citron M L, Johnston-Early A, Fossieck BE, Jr. Safety and efficacy of continuous intravenous morphine for severe cancer pain. Am J Med 1984; 77: 199–204
- DeChristoforo R, Corden B J, Hood J C. High dose morphine infusion complicated by chlorbutol induced somnolence. Ann Intern Med 1983; 98: 335–336
- Stuart G J, Davey E B, Wright S E. Continuous intravenous morphine infusions for terminal pain control. A retrospective review. Drug Intell Clin Pharm 1986; 20: 968–972
- Sriwatanakul K, Kelvie Lasagna W. L. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983; 34: 234–239
- Portnoy R K. Continuous intravenous infusion of opioid drugs. Med Clin North Am 1987; 71: 233–241